Cart
sales@molnova.com
Maohuoside A
CAS No. 128988-55-6
Maohuoside A( —— )
Catalog No. M23450 CAS No. 128988-55-6
Maohuoside A promotes osteogenesis of rat mesenchymal stem cells via BMP and MAPK signaling pathways.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 244 | In Stock |
|
| 5MG | 198 | In Stock |
|
| 10MG | 294 | In Stock |
|
| 25MG | 468 | In Stock |
|
| 50MG | 607 | In Stock |
|
| 100MG | 830 | In Stock |
|
| 200MG | 1097 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMaohuoside A
-
NoteResearch use only, not for human use.
-
Brief DescriptionMaohuoside A promotes osteogenesis of rat mesenchymal stem cells via BMP and MAPK signaling pathways.
-
DescriptionMaohuoside A promotes osteogenesis of rat mesenchymal stem cells via BMP and MAPK signaling pathways.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
Targetp38 MAPK
-
RecptorMAPK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number128988-55-6
-
Formula Weight548.5
-
Molecular FormulaC27H32O12
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESO=C1C(O)=C(C2=CC=C(OC)C=C2)OC3=C(CCC(C)(O)C)C(O[C@H]4[C@@H]([C@H]([C@@H]([C@@H](CO)O4)O)O)O)=CC(O)=C13
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ming C , Li G , Tao K , et al. Maohuoside A Acts in a BMP‐dependent Manner during Osteogenesis[J]. Phytotherapy Research, 2013, 27(8):1179-1184.
molnova catalog
related products
-
PAF (C16)
PAF (C16) is a potent MAPK and MEK/ERK activator that induces increased vascular permeability. PAF (C16) (PAF (C16)) is a platelet-activating factor, a phospholipid-derived mediator and a ligand for PAF G protein-coupled receptor (PAFR). PAF (C16) has shown anti-apoptotic and anti-inflammatory activity in vitro, inhibiting Caspase-dependent apoptosis by interacting with its receptor (PAF-R) to perform cell signaling.
-
HPK1-IN-7
HPK1-IN-7 is an orally active HPK1 inhibitor. It shows selectivity against IRAK4 (59 nM) and GLK (140 nM).
-
UR13870
UR-13870 (Org 48762-0) is an orally active and selective inhibitor of p38 mitogen-activated protein kinase (MAPK), which prevents bone damage in collagen-induced arthritis in mice.
